Neurology Research International最新文献

{"title":"Effectiveness and Adverse Effect of Intravenous Lacosamide in Nonconvulsive Status Epilepticus and Acute Repetitive Seizures in Children.","authors":"Monsicha Ngampoopun,&nbsp;Piradee Suwanpakdee,&nbsp;Nattapon Jaisupa,&nbsp;Charcrin Nabangchang","doi":"10.1155/2018/8432859","DOIUrl":"https://doi.org/10.1155/2018/8432859","url":null,"abstract":"<p><p>Nonconvulsive status epilepticus (NCSE) and acute repetitive seizures (ARS) are associated with significant morbidity and mortality. Due to the lack of randomized-controlled trials of intravenous antiepileptic drugs (AEDs) in these conditions, trials of a new generation of AEDs in this aspect are needed. A prospective interventional study was conducted in children under 18 years of age with NCSE or ARS who either had contraindication to or were refractory to first-line AEDs and received intravenous lacosamide. Demographic data, the efficacy of treatment, and adverse effects were recorded. Eleven patients with a median age of 11 years, predominantly female (72.7%), were enrolled. Average loading dose was 227 mg (8.3 mg/kg/dose) and average daily maintenance dose was 249 mg (4.6 mg/kg/dose). All patients (100%) experienced a reduction in seizure frequency within 24 hours. Eight of eleven patients (72.7%) experienced a reduction in seizure frequency of more than 50% by the end of the study, and one patient became seizure-free. In terms of adverse events, one patient had a bradycardia without prolongation of the PR interval. Interestingly, there was a case of neuronal ceroid lipofuscinosis in which a significant improvement in seizure control was achieved. The results indicate that intravenous lacosamide may be an alternative treatment for NCSE or ARS in children. To our knowledge, this is the first study on the use of intravenous lacosamide in Asian children. This study is registered to Thai Clinical Trials Registry (TCTR) and the trial registration number is TCTR20180508004.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"8432859"},"PeriodicalIF":1.5,"publicationDate":"2018-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/8432859","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36293205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Early Outcomes of Nurse Case Management in Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator: A Prospective Randomized Controlled Trial.","authors":"Urai Kummarg,&nbsp;Siriorn Sindhu,&nbsp;Sombat Muengtaweepongsa","doi":"10.1155/2018/1717843","DOIUrl":"https://doi.org/10.1155/2018/1717843","url":null,"abstract":"<p><strong>Background: </strong>Intravenous recombinant tissue plasminogen activator (i.v. rt-PA) is the milestone treatment for patients with acute ischemic stroke. Stroke Fast Track (SFT) facilitates time reduction, guarantees safety, and promotes good clinical outcomes in i.v. rt-PA treatment. Nursing case management is a healthcare service providing clinical benefits in many specific diseases. The knowledge about the efficacy of a nurse case management for Stroke Fast Track is limited. We aim to study the effect of nurse case management on clinical outcomes in patients with acute ischemic stroke involving intravenous recombinant tissue plasminogen activator (i.v. rt-PA) treatment.</p><p><strong>Methods: </strong>Seventy-six patients with acute ischemic stroke who received i.v. rt-PA treatment under Stroke Fast Track protocol of Thammasat University Hospital were randomized into two groups. One group was assigned to get standard care (control) while another group was assigned to get standard care under a nurse case management. The National Institute of Health Stroke Scale (NIHSS) at 24 hours after treatment between the control and the experimental groups was evaluated.</p><p><strong>Results: </strong>Time from triage to treatment in the experimental group was significantly faster than in the control group (mean = 39.02 and 59.37 minutes, respectively; p=.001). The NIHSS at 24 hours after treatment in the nurse case management group was significantly improved as compared to the control group (p=.001). No symptomatic intracranial hemorrhage (sICH) was detected at 24 hours after onset in both groups.</p><p><strong>Conclusion: </strong>The nurse case management should provide some benefits in the acute stroke system. Although the early benefit is demonstrated in our study, further studies are needed to ensure the long-term benefit and confirm its profit in patients with acute ischemic stroke.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"1717843"},"PeriodicalIF":1.5,"publicationDate":"2018-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/1717843","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36288324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can Chaotic Analysis of Electroencephalogram Aid the Diagnosis of Encephalopathy?","authors":"Jisu Elsa Jacob,&nbsp;Ajith Cherian,&nbsp;K Gopakumar,&nbsp;Thomas Iype,&nbsp;Doris George Yohannan,&nbsp;K P Divya","doi":"10.1155/2018/8192820","DOIUrl":"https://doi.org/10.1155/2018/8192820","url":null,"abstract":"<p><p>Chaotic analysis is a relatively novel area in the study of physiological signals. Chaotic features of electroencephalogram have been analyzed in various disease states like epilepsy, Alzheimer's disease, sleep disorders, and depression. All these diseases have primary involvement of the brain. Our study examines the chaotic parameters in metabolic encephalopathy, where the brain functions are involved secondary to a metabolic disturbance. Our analysis clearly showed significant lower values for chaotic parameters, correlation dimension, and largest Lyapunov exponent for EEG in patients with metabolic encephalopathy compared to normal EEG. The chaotic features of EEG have been shown in previous studies to be an indicator of the complexity of brain dynamics. The smaller values of chaotic features for encephalopathy suggest that normal complexity of brain function is reduced in encephalopathy. To the best knowledge of the authors, no similar work has been reported on metabolic encephalopathy. This finding may be useful to understand the neurobiological phenomena in encephalopathy. These chaotic features are then utilized as feature sets for Support Vector Machine classifier to identify cases of encephalopathy from normal healthy subjects yielding high values of accuracy. Thus, we infer that chaotic measures are EEG parameters sensitive to functional alterations of the brain, caused by encephalopathy.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"8192820"},"PeriodicalIF":1.5,"publicationDate":"2018-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/8192820","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36308896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus.","authors":"Mohammad-Amin Khajezadeh,&nbsp;Gholamreza Zamani,&nbsp;Bobak Moazzami,&nbsp;Zahra Nagahi,&nbsp;Mahdie Mousavi-Torshizi,&nbsp;Vahid Ziaee","doi":"10.1155/2018/2548142","DOIUrl":"https://doi.org/10.1155/2018/2548142","url":null,"abstract":"<p><strong>Objective: </strong>Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by multisystem involvement, including the nervous system. In the present study, we aimed to assess neuropsychiatric manifestations in juvenile-onset systemic lupus erythematosus (JSLE) in Iran.</p><p><strong>Methods: </strong>One hundred and forty-six pediatric onset patients with SLE who had registered in our pediatric rheumatology database were evaluated prospectively and cross sectionally within 2013-2015. Data including sex, age, age at the time of diagnosis, age at the time of study, physical examination, laboratory review, and neuropsychiatric inventory were extracted from this database. Classification of neuropsychiatric JSLE was according to the 1999 American College of Rheumatology (ACR) neuropsychiatric manifestations of SLE case definitions.</p><p><strong>Result: </strong>A total number of 41 patients with neuropsychiatric symptoms were selected. The patients' average age was 12.2 years. The most common neuropsychiatric symptoms were seizures, migraine, and depression. The mean age at the onset of symptoms was 10.2 ± 3 years. Mean follow-up period was 57±34 (range: 12-120) months. From 41 SLE patients, 18 (43.9) presented symptoms at the time of diagnosis. In thirteen (31.7%) patients, neurological symptoms were developed more than 1 year after SLE diagnosis. Headache was the most common feature (13%), followed by seizure (9.5%) and chorea (3.4%). Other neurological manifestations included cranial nerve involvement (0.7%), loss of consciousness (2.7%), and impaired deep tendon reflex neuropathy (2.5%). The least common neuropsychiatric JSLE manifestation was aseptic meningitis seen in only one patient (0.7%).</p><p><strong>Conclusion: </strong>The presence of headache, mood disorders, psychosis, depression, and other neuropsychological manifestations in a patient with JSLE should prompt investigations into diagnosis of the primary nervous system involvement in order to reduce mortality and morbidity.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"2548142"},"PeriodicalIF":1.5,"publicationDate":"2018-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/2548142","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36308895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Perceived Social Stigma of People with Epilepsy with regard to the Question of Employability.","authors":"Jéssica Lopes de Souza,&nbsp;Aline Scardoeli Faiola,&nbsp;Carmen Silvia Molleis Galego Miziara,&nbsp;Maria Luiza Giraldes de Manreza","doi":"10.1155/2018/4140508","DOIUrl":"https://doi.org/10.1155/2018/4140508","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the perceived social stigma of people with epilepsy with regard to the question of employability.</p><p><strong>Methods: </strong>A structured questionnaire was given to two groups of people with chronic diseases: those with epilepsy (study group) and those with heart disease (control group). The questions concerned employability.</p><p><strong>Results: </strong>Having epilepsy was more strongly associated with higher unemployment rates (<i>p</i> < 0.0001); job layoffs (<i>p</i> = 0.001); being unfit to work (<i>p</i> < 0.0001); feeling shame for having the disease (<i>p</i> = 0.014); absence of partners (<i>p</i> = 0.026); and depression (<i>p</i> = 0.004). The tendency to hide their disease from their employers was similar for the two groups.</p><p><strong>Conclusion: </strong>The age discrepancy between groups was an important limiting factor of this study. However, despite the limited number of participants and the age difference between the groups, there is no impediment in stating that people with epilepsy show high rates of unemployment, depression, and stigma.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"4140508"},"PeriodicalIF":1.5,"publicationDate":"2018-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/4140508","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36189339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ethnicity Influences Corpus Callosum Dimensions.","authors":"Hilda Nouri Hosseini,&nbsp;Mohammad Reza Mohammadi,&nbsp;Mohsen Aarabi,&nbsp;Narges Mohammadi,&nbsp;Mohammad Jafar Golalipour","doi":"10.1155/2018/8916035","DOIUrl":"https://doi.org/10.1155/2018/8916035","url":null,"abstract":"<p><strong>Background and objective: </strong>Corpus callosum (CC), the main white matter cable which connects two hemispheres of brain, is important in special procedures such as stereotaxic surgeries vary in size, in different populations. Determination of possible size differences in ethnical groups has special values.</p><p><strong>Patients and methods: </strong>The size of the CC on midsagittal view was determined in 76 normal male subjects using MRI of brain hemispheres in northern Iran. The size of rostrum, body, splenium, length, and height of CC was measured for each subject. The width of the body of the corpus callosum (<i>B</i>), the anterior to posterior length (<i>L</i>) and the maximum height (<i>H</i>) of the corpus callosum, and ratios <i>B</i>/<i>L</i> and <i>B</i>/<i>H</i> were also calculated.</p><p><strong>Results: </strong>The longitudinal dimensions of the CC were 70.21 mm and 74.05 mm in native Fars and Turkmens, respectively (<i>P</i> < 0.05). The heights were 25 mm and 25.75 mm in native Fars and Turkmen subjects, respectively. The width of CC in Turkmen people was significantly higher than native Fars people (<i>P</i> < 0.05). The Evans index in Turkmen group (0.314) was significantly higher than in native Fars (0.3). The <i>B</i>/<i>L</i> and <i>B</i>/<i>H</i> ratios were nonsignificantly different between two groups.</p><p><strong>Conclusion: </strong>The CC parameters vary in different ethnical groups in northern Iran.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"8916035"},"PeriodicalIF":1.5,"publicationDate":"2018-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/8916035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36181979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk Factors Associated with Severity of Nongenetic Intellectual Disability (Mental Retardation) among Children Aged 2-18 Years Attending Kenyatta National Hospital.","authors":"Mathieu Nemerimana,&nbsp;Margaret Njambi Chege,&nbsp;Eunice Ajode Odhiambo","doi":"10.1155/2018/6956703","DOIUrl":"https://doi.org/10.1155/2018/6956703","url":null,"abstract":"<p><strong>Background: </strong>Many of the nongenetic causal risk factors of intellectual disability (ID) can be prevented if they are identified early. There is paucity on information regarding potential risk factors associated with this condition in Kenya. This study aimed to establish risk factors associated with severity of nongenetic intellectual disability (ID) among children presenting with this condition at Kenyatta National Hospital (KNH).</p><p><strong>Methods: </strong>A hospital-based cross-sectional study was conducted over the period between March and June 2017 in pediatric and child/youth mental health departments of Kenyatta National Hospital (KNH), Kenya. It included children aged 2-18 years diagnosed with ID without underlying known genetic cause.</p><p><strong>Results: </strong>Of 97 patients with nongenetic ID, 24% had mild ID, 40% moderate, 23% severe-profound, and 10% unspecified ID. The mean age of children was 5.6 (±3.6) years. Male children were predominant (62%). Three independent factors including \"labor complications\" [AOR = 9.45, 95% CI = 1.23-113.29, <i>P</i> = 0.036], \"admission to neonatal intensive care unit\" [AOR = 8.09, 95% CI = 2.11-31.07, <i>P</i> = 0.002], and \"cerebral palsy\" [AOR = 21.18, CI = 4.18-107.40, <i>P</i> ≤ 0.001] were significantly associated with increased risk of severe/profound nongenetic ID.</p><p><strong>Conclusion: </strong>The present study findings suggest that perinatal complications as well as postnatal insults are associated with increased risk of developing severe-profound intellectual disability, implying that this occurrence may be reduced with appropriate antenatal, perinatal, and neonatal healthcare interventions.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"6956703"},"PeriodicalIF":1.5,"publicationDate":"2018-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/6956703","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36177998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of High-Dose and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcomes in Patient with Acute Ischemic Stroke: A Randomized, Double-Blind, Parallel, Controlled Trial.","authors":"Nattaphol Uransilp, Pannawat Chaiyawatthanananthn, Sombat Muengtaweepongsa","doi":"10.1155/2018/7268924","DOIUrl":"10.1155/2018/7268924","url":null,"abstract":"<p><strong>Backgrounds: </strong>Stroke is the leading cause of death and long-term disability. Oxidative stress is elevated during occurrence of acute ischemic stroke (AIS). Soluble LOX-1 (sLOX-1) and NO are used as biomarkers for vascular oxidative stress that can reflect stabilization of atherosclerotic plaque. Previous study showed that simvastatin can reduce oxidative stress and LOX-1 expression.</p><p><strong>Objectives: </strong>To evaluate neurological outcomes and serum sLOX-1 and NO levels in patients with AIS treatment with low dose 10 mg/day and high dose 40 mg/day of simvastatin.</p><p><strong>Methods: </strong>65 patients with AIS within 24 hours after onset were randomized to treatment with simvastatin 10 mg/day or 40 mg/day for 90 days. Personal data and past history of all patients were recorded at baseline. The blood chemistries were measured by standard laboratory techniques. Serum sLOX-1 and NO levels and neurological outcomes including NIHSS, mRS, and Barthel index were tested at baseline and Day 90 after simvastatin therapy.</p><p><strong>Results: </strong>Baseline characteristics were not significantly different in both groups except history of hypertension. Serum sLOX-1 and NO levels significantly reduce in both groups (sLOX-1 = 1.19 ± 0.47 and 0.98 ± 0.37 ng/ml; NO = 49.28 ± 7.21 and 46.59 ± 9.36 <i>μ</i>mol/l) in 10 mg/day and 40 mg/day simvastatin groups, respectively. Neurological outcomes including NIHSS, mRS, and Barthel index significantly improve in both groups. However, no difference in NO level and neurological outcomes was found at 90 days after treatment as compared between low dose 10 mg/day and high dose 40 mg/day of simvastatin.</p><p><strong>Conclusion: </strong>High-dose simvastatin might be helpful to reduce serum sLOX-1. But no difference in clinical outcomes was found between high- and low-dose simvastatin. Further more intensive clinical trial is needed to confirm the appropriate dosage of simvastatin in patients with acute ischemic stroke. This trial is registered with ClinicalTrials.gov ID: NCT03402204.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"7268924"},"PeriodicalIF":1.5,"publicationDate":"2018-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36177999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Depressive Symptoms in Individuals after Stroke in a Home-Based Rehabilitation Setting.","authors":"Julianne Vermeer,&nbsp;Amanda McIntyre,&nbsp;Shannon Janzen,&nbsp;Danielle Rice,&nbsp;Laura Allen,&nbsp;David Ure,&nbsp;Robert Teasell","doi":"10.1155/2018/1621830","DOIUrl":"https://doi.org/10.1155/2018/1621830","url":null,"abstract":"<p><p>Poststroke depression has been shown to affect rehabilitation progress. This study evaluated patients after stroke who actively participated in a home-based rehabilitation program to determine variables that correlated with depressive symptoms in this population. A retrospective review of patients who were provided rehabilitation by Community Stroke Rehabilitation Team clinicians between January 1, 2009, and September 30, 2015, was completed. Logistic regression analysis was conducted to determine which demographic and outcome variables (Functional Independence Measure [FIM™] and Reintegration to Normal Living Index [RNLI]) were independently associated with depressive symptoms, as defined by Patient Health Questionnaire (PHQ-9) scores. 889 patients (53.2% male, mean age = 69.8 years) were included. Based on PHQ-9 scores, 89.7% of patients presented with no or mild depressive symptoms (PHQ-9 < 10) and 10.3% were considered to have moderate to severe depressive symptoms (PHQ-9 ≥ 10). The regression demonstrated that referral from outpatient, community care access centre, or community settings (OR = 1.89, <i>p</i> = 0.04), low RNLI scores (OR = 0.92; <i>p</i> = 0.001), and younger age (OR = 0.96; <i>p</i> < 0.001) predicted patients having moderate to severe depressive symptoms. Given the impact of poststroke depression on rehabilitation, clinicians should consider the potential impact of referral source, community reintegration, and age when monitoring and treating depressive symptoms.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"1621830"},"PeriodicalIF":1.5,"publicationDate":"2018-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/1621830","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36177997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Number of Repetitions and Number of Hours of Shaping Practice during Constraint-Induced Movement Therapy: A Randomized Controlled Trial.","authors":"Auwal Abdullahi","doi":"10.1155/2018/5496408","DOIUrl":"https://doi.org/10.1155/2018/5496408","url":null,"abstract":"<p><strong>Background: </strong>Constraint-induced movement therapy (CIMT) is effective in improving motor outcomes after stroke. However, its existing protocols are resource-intensive and difficult to implement. The aim of this study is to design an easier CIMT protocol using number of repetitions of shaping practice.</p><p><strong>Method: </strong>The study design was randomized controlled trial. Participants within 4 weeks after stroke were recruited at Murtala Muhammad Specialist Hospital. They were randomly assigned to groups A, B, C, and D. Group A received 3 hours of traditional therapy. Groups B, C, and D received modified CIMT consisting of 3 hours of shaping practice per session, 300 repetitions of shaping practice in 3 sessions, and 600 repetitions of shaping practice in 3 sessions per day, respectively, and constraint for 90% of the waking hours. All treatment protocols were administered 5 times per week for 4 weeks. The primary outcome was measured using upper limb Fugl-Meyer assessment, while the secondary outcome was measured using motor activity log, Wolf Motor Function Test, and upper limb self-efficacy test at baseline, 2 weeks, and 4 weeks after intervention.</p><p><strong>Result: </strong>There were 48 participants 4 weeks after intervention. The result showed that there was no significant difference between groups at baseline (<i>p</i> > 0.05). Within-group improvements attained minimal clinically important difference (MCID) in modified CIMT and 300 repetitions and 600 repetitions groups.</p><p><strong>Conclusion: </strong>Number of repetitions of shaping practice significantly improved motor function, real-world arm use, and upper limb self-efficacy after stroke. Therefore, it seems to be a simple alternative for the use of number of hours.</p><p><strong>Trial registration: </strong>This trial is registered with Pan African Clinical Trial Registry (registration number: PACTR201610001828172) (date of registration: 21/10/2016).</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2018 ","pages":"5496408"},"PeriodicalIF":1.5,"publicationDate":"2018-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/5496408","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36137316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}